We gratefully acknowledge the collaboration of the Tulane University and Kenema Government Hospital Lassa Fever Team in Kenema, the leadership of the University of Sierra Leone Faculty of Nursing, the investigators and laboratory team of the EBOVAC Vaccine Trial in Kambia, and the logistic support of the UK Public Health Rapid Support Team programme staff. We thank Professor Nick Andrews of the Statistic Unit of Public Health England for his assistance with mixed methods modelling for the cut-offs, and Tansy Edwards, Assistant Professor in Medical Statistics of the London School of Hygiene & Tropical Medicine Tropical Epidemiology Group for her assistance in sample size calculation. We also thank the LSHTM Open Research Kits team (http://opendatakit.lshtm.ac.uk/) for their support in developing the studyâ€™s mobile-based questionnaire.
The views expressed in this publication are those of the authors and not necessarily those of the National Health Service, the National Institute for Health Research or the Department of Health and Social Care.